A. B. Renwick

1.6k total citations
34 papers, 1.4k citations indexed

About

A. B. Renwick is a scholar working on Pharmacology, Oncology and Cancer Research. According to data from OpenAlex, A. B. Renwick has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 17 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in A. B. Renwick's work include Pharmacogenetics and Drug Metabolism (28 papers), Drug Transport and Resistance Mechanisms (15 papers) and Carcinogens and Genotoxicity Assessment (8 papers). A. B. Renwick is often cited by papers focused on Pharmacogenetics and Drug Metabolism (28 papers), Drug Transport and Resistance Mechanisms (15 papers) and Carcinogens and Genotoxicity Assessment (8 papers). A. B. Renwick collaborates with scholars based in United Kingdom, United States and France. A. B. Renwick's co-authors include Brian G. Lake, Roger J. Price, J.A. Beamand, J. Michael Tredger, D. Gareth Walters, S. Ball, Patricia S. Watts, Alan R. Boobis, Dominic Surry and David C. Evans and has published in prestigious journals such as Food and Chemical Toxicology, Toxicology and Drug Metabolism and Disposition.

In The Last Decade

A. B. Renwick

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. B. Renwick United Kingdom 24 857 347 341 137 134 34 1.4k
Michael D. Aleo United States 24 769 0.9× 694 2.0× 309 0.9× 103 0.8× 63 0.5× 51 2.0k
Donald Tweedie United States 24 834 1.0× 499 1.4× 568 1.7× 130 0.9× 22 0.2× 49 1.6k
Philippe Coassolo Switzerland 20 577 0.7× 271 0.8× 350 1.0× 81 0.6× 33 0.2× 45 1.4k
Kazuhide Iwasaki Japan 26 931 1.1× 502 1.4× 683 2.0× 134 1.0× 22 0.2× 68 2.0k
S. Ball United States 21 1.5k 1.8× 599 1.7× 745 2.2× 295 2.2× 25 0.2× 28 2.3k
Nathalie Chauret Canada 25 616 0.7× 607 1.7× 315 0.9× 410 3.0× 25 0.2× 64 1.9k
Lydiane Pichard France 18 1.3k 1.6× 450 1.3× 808 2.4× 191 1.4× 21 0.2× 33 2.2k
L. Vereczkey Hungary 21 547 0.6× 341 1.0× 358 1.0× 182 1.3× 16 0.1× 89 1.4k
Jasminder Sahi United States 21 539 0.6× 379 1.1× 479 1.4× 57 0.4× 17 0.1× 44 1.3k
JoAnn Scatina United States 22 681 0.8× 483 1.4× 318 0.9× 251 1.8× 28 0.2× 56 1.6k

Countries citing papers authored by A. B. Renwick

Since Specialization
Citations

This map shows the geographic impact of A. B. Renwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. B. Renwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. B. Renwick more than expected).

Fields of papers citing papers by A. B. Renwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. B. Renwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. B. Renwick. The network helps show where A. B. Renwick may publish in the future.

Co-authorship network of co-authors of A. B. Renwick

This figure shows the co-authorship network connecting the top 25 collaborators of A. B. Renwick. A scholar is included among the top collaborators of A. B. Renwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. B. Renwick. A. B. Renwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Price, Roger J., A. B. Renwick, D. Gareth Walters, Philip J. Young, & Brian G. Lake. (2003). Metabolism of nicotine and induction of CYP1A forms in precision-cut rat liver and lung slices. Toxicology in Vitro. 18(2). 179–185. 26 indexed citations
2.
Lake, Brian G., Clive Meredith, Mary P. Scott, A. B. Renwick, & Roger J. Price. (2003). Use of cultured precision-cut rat lung slices to study the in vitro induction of pulmonary cytochrome P450 forms. Xenobiotica. 33(7). 691–702. 20 indexed citations
3.
Salonen, Jarmo S., Leena Nyman, Alan R. Boobis, et al.. (2003). COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS. Drug Metabolism and Disposition. 31(9). 1093–1102. 55 indexed citations
4.
Meredith, Clive, Mary P. Scott, A. B. Renwick, Roger J. Price, & Brian G. Lake. (2003). Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices. Xenobiotica. 33(5). 511–527. 66 indexed citations
5.
Edwards, Robert J., Roger J. Price, Patricia S. Watts, et al.. (2003). Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices. Drug Metabolism and Disposition. 31(3). 282–288. 75 indexed citations
6.
Renwick, A. B., S. Ball, J. Michael Tredger, et al.. (2002). Inhibition of zaleplon metabolism by cimetidine in the human liver:in vitrostudies with subcellular fractions and precision-cut liver slices. Xenobiotica. 32(10). 849–862. 52 indexed citations
7.
Lake, Brian G., et al.. (2002). Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase. Xenobiotica. 32(10). 835–847. 71 indexed citations
8.
Subrahmanyam, Vangala V., A. B. Renwick, D. Gareth Walters, et al.. (2002). Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms. Xenobiotica. 32(6). 521–534. 4 indexed citations
11.
Pelkonen, Olavi, Päivi Myllynen, Päivi Taavitsainen, et al.. (2001). Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derivedin vitrosystems. Xenobiotica. 31(6). 321–343. 49 indexed citations
12.
Lake, Brian G., Roger J. Price, Barry Phillips, et al.. (2001). Lack of effect of furfural on unscheduled DNA synthesis in the in vivo rat and mouse hepatocyte DNA repair assays and in precision-cut human liver slices. Food and Chemical Toxicology. 39(10). 999–1011. 9 indexed citations
13.
Lake, Brian G., et al.. (1998). 3,3′-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices. Xenobiotica. 28(8). 803–811. 31 indexed citations
15.
Renwick, A. B., et al.. (1998). Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms. Xenobiotica. 28(4). 337–348. 42 indexed citations
16.
Lake, Brian G., S. Ball, A. B. Renwick, et al.. (1997). Induction of CYP3A isoforms in cultured precisioncut human liver slices. Xenobiotica. 27(11). 1165–1173. 31 indexed citations
17.
Lake, Brian G., et al.. (1996). Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices. Xenobiotica. 26(3). 297–306. 69 indexed citations
18.
Price, Roger J., et al.. (1996). Metabolism of [ring-U-14C] agaritine by precision-cut rat, mouse and human liver and lung slices. Food and Chemical Toxicology. 34(7). 603–609. 10 indexed citations
19.
Price, Roger J., et al.. (1996). Comparison of the toxicity of allyl alcohol, coumarin and menadione in precision-cut rat, guinea-pig, Cynomolgus monkey and human liver slices. Archives of Toxicology. 71(1-2). 107–111. 22 indexed citations
20.
Price, Roger J., et al.. (1995). Toxicity of 3-methylindole, 1-nitronaphthalene and paraquat in precision-cut rat lung slices. Archives of Toxicology. 69(6). 405–409. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026